SG

Shubham Gupta

Active Director Director DIN 09364762
DIN 09364762 First appointment Oct 2021 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2021
Shareholding value •••• Premium profile

About Shubham Gupta

Data last updated:

Shubham Gupta is a Director at Booty Pharma Private Limited (since 2021). The company operates in Pharma. Booty Pharma Private Limited reported revenue of ₹1.87 Cr (FY 2024).

DIN 09364762
Primary Designation Director
Industry Pharma
First Appointment 19 Oct 2021
Oldest Company Age 31 yrs
Largest company Booty Pharma Private Limited · ₹1.87 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Booty Pharma Private Limited U24231UP1995PTC017861
Director19 Oct 20211995₹1.87 Cr (FY 2024)Active

Board colleagues of Shubham Gupta

Directorship timeline

Open interactive timeline →
Booty Pharma Private Limited
Premium access

Shareholding and investment profile for Shubham Gupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shubham Gupta

Shubham Gupta currently holds 1 directorship: Booty Pharma Private Limited (Director, since 19 Oct 2021, revenue ₹1.87 Cr (FY 2024)).

Shubham Gupta was first appointed on 19 Oct 2021 as Director at Booty Pharma Private Limited.

The current boards of Shubham Gupta's companies include Meera Gupta (Booty Pharma Private Limited), Ravi Kant Gupta (Booty Pharma Private Limited), Reeshabh Gupta (Booty Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available